• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 422395 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1413903574 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1413903574 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Stock Investors Bid Up Shares of Isis Pharmaceuticals, Up 2.1%

Published on Tue, 01/15/2013 - 13:17
By Peter Chu

One of today's stocks on the move is Isis Pharmaceuticals (NASDAQ:ISIS), up 2.1% to $13.98. The Dow Jones Industrial Average is now trading fractionally lower to 13,504 and the S&P is trading fractionally lower to 1,470.

Isis Pharmaceuticals (NASDAQ:ISIS) is currently priced 23.1% above its average consensus analyst price target of $10.75. The stock should find initial support at its 200-day moving average (MA) of $10.92 and further support at its 50-day MA of $9.68.

In the past 52 weeks, Isis Pharmaceuticals share prices have been bracketed by a low of $6.25 and a high of $15.61 and are now at $13.98, 124% above that low price. The 200-day and 50-day moving averages have moved 0.64% higher and 2.92% higher over the past week, respectively.

Isis Pharmaceuticals, Inc. discovers and develops novel human therapeutic compounds. The company currently has various compounds in clinical trials for a variety of diseases such as Crohn's disease, psoriasis, asthma, and cancer. Isis' broad medical chemistry and biology research programs support efforts in both antisense and small molecule drug delivery.

By Peter Chu
pchu@fnno.com

Latest News from FNNO

Watch for Shares of AmerisourceBergen (A...

Shares of AmerisourceBergen (NYSE:ABC) have bullishly opened above the pivot of $75.54 ...

Rowan (RDC) Crosses Pivot Point Resistan...

Shares of Rowan (NYSE:RDC) opened today above their pivot of $22.85 and have already re ...

Watch for Shares of SUPERVALU (SVU) to A...

SUPERVALU (NYSE:SVU) has opened bullishly above the pivot of $8.20 today and has reache ...

Next Resistance Level for Yum! Brands (Y...

Shares of Yum! Brands (NYSE:YUM) opened today above their pivot of $68.85 and have alre ...

Pioneer Natural Resources (PXD) Crosses ...

Shares of Pioneer Natural Resources (NYSE:PXD) have bullishly opened above the pivot of ...

Hot Stock: CEL-SCI, Shares Drop 20.6% (C...

CEL-SCI (AMEX:CVM) is one of today's worst performing penny stocks, down 20.6% to $0.68 ...

Gannett (GCI) Approaches New Upside Targ...

Shares of Gannett (NYSE:GCI) opened today above their pivot of $28.76 and have already ...

Watch for Shares of Lowe's (LOW) to Appr...

Shares of Lowe's (NYSE:LOW) opened today above their pivot of $53.16 and have already r ...